Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients

MeSH terms

• Aged
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Dasatinib / therapeutic use
• Disease Progression
• Female
• Fusion Proteins, bcr-abl / genetics*
• Fusion Proteins, bcr-abl / metabolism
• Gene Expression
• Hematopoietic Stem Cell Transplantation*
• Humans
• Imatinib Mesylate / therapeutic use
• Interferons / therapeutic use
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
• Longitudinal Studies
• Male
• Middle Aged
• Mutation
• Pyrimidines / therapeutic use
• RNA, Messenger / genetics*
• RNA, Messenger / metabolism
• RNA-Binding Proteins / genetics*
• RNA-Binding Proteins / metabolism
• Retrospective Studies
• Survival Analysis